KB
Kate Blumenstein
Credentials: ·
History
- 2024–2027
Residency
- 2020–2024
Medical School
Research
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice
Annals of Neurology · 2018 · 121 citations
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
Molecular Therapy — Nucleic Acids · 2017 · 104 citations
Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis
Journal of Neuroscience · 2022 · 44 citations
3 papers
- EW
2 papers
- AD
1 paper
- AP
1 paper
- JD
1 paper
1 paper
1 paper
1 paper